Order Article Reprints

Wu Z-H, Li N, Gao Z-Z, Chen G, Nie L, Zhou Y-Q, Jiang M-Z, Chen Y, Chen J, Mei X-F, et al. Development of the Novel Bifunctional Fusion Protein BR102 That Simultaneously Targets PD-L1 and TGF-β for Anticancer Immunotherapy. Cancers. 2022; 14(19):4964. https://doi.org/10.3390/cancers14194964

Wu, Zhen-Hua, Na Li, Zhang-Zhao Gao, Gang Chen, Lei Nie, Ya-Qiong Zhou, Mei-Zhu Jiang, Yao Chen, Juan Chen, Xiao-Fen Mei, and et al. 2022. "Development of the Novel Bifunctional Fusion Protein BR102 That Simultaneously Targets PD-L1 and TGF-β for Anticancer Immunotherapy" Cancers 14, no. 19: 4964. https://doi.org/10.3390/cancers14194964

Wu, Z.-H., Li, N., Gao, Z.-Z., Chen, G., Nie, L., Zhou, Y.-Q., Jiang, M.-Z., Chen, Y., Chen, J., Mei, X.-F., Hu, F., & Wang, H.-B. (2022). Development of the Novel Bifunctional Fusion Protein BR102 That Simultaneously Targets PD-L1 and TGF-β for Anticancer Immunotherapy. Cancers, 14(19), 4964. https://doi.org/10.3390/cancers14194964